跳至主要内容
临床试验/NCT03770013
NCT03770013已完成不适用

Role of Co-administered Dexmedetomidine Or Clonidine With Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Elective Caesarean Section: A Randomized, Double-blind Controlled Trial

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
The time for first rescue analgesia after the TAP block

研究概览

简要总结

Aim to study the efficacy of co-administered Dexmedetomidine Or Clonidine with Bupivacaine and that of bupivacaine 0.25% alone for Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia in Patients Undergoing Elective Caesarean Section.

  • Group 1: bupivacaine 0.25% + Dexmedetomidine 0.5 mcg/kg (a total volume of 40 ml (20 ml each side) was used for the TAP block.)
  • Group 2: 20 ml bupivacaine+1ug/kg clonidine bilaterally (a total volume of 40 ml (20 ml each side) was used for the TAP
  • Group3: bupivacaine 0.25% + placebo (a total volume of 40 ml (20 ml each side) was used for the TAP A prospective Randomized Interventional double-blind study.

详细描述

Women, following Caesarean delivery, have even more compelling reasons to receive optimal post-operative pain relief, for improved maternal and neonatal well-being. Also, adequate pain relief helps the patient to ambulate early and prevent any thrombotic incidents . Dexmedetomidine, an imidazole compound, is the pharmacologically active dextroisomer of medetomidine that displays specific and selective α 2-adrenoceptor agonist activity and causes sedation, analgesia without any delirium, or respiratory depression. The mechanism of action is unique and differs from those of currently used agents, including clonidine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double-blind study.

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • parturients scheduled to undergo cesarean section under spinal anesthesia

排除标准

  • Patients who refused spinal anesthesia
  • women with chronic pelvic pain or on chronic morphine use
  • history of drug allergy
  • coagulation disorder

研究组 & 干预措施

bupivacaine 0.25% and Dexmedetomidine

Active Comparator

bupivacaine 0.25% + Dexmedetomidine 0.5 mcg/kg (a total volume of 40 ml (20 ml each side) was used for the TAP block.)

干预措施: bupivacaine (Drug)

bupivacaine 0.25% and Dexmedetomidine

Active Comparator

bupivacaine 0.25% + Dexmedetomidine 0.5 mcg/kg (a total volume of 40 ml (20 ml each side) was used for the TAP block.)

干预措施: Dexmedetomidine (Drug)

bupivacaine and clonidine

Active Comparator

20 ml bupivacaine+1ug/kg clonidine bilaterally (a total volume of 40 ml (20 ml each side) was used for the TAP

干预措施: bupivacaine (Drug)

bupivacaine and clonidine

Active Comparator

20 ml bupivacaine+1ug/kg clonidine bilaterally (a total volume of 40 ml (20 ml each side) was used for the TAP

干预措施: clonidine (Drug)

bupivacaine and placebo

Placebo Comparator

bupivacaine 0.25% + placebo (a total volume of 40 ml (20 ml each side) was used for the TAP

干预措施: bupivacaine (Drug)

bupivacaine and placebo

Placebo Comparator

bupivacaine 0.25% + placebo (a total volume of 40 ml (20 ml each side) was used for the TAP

干预措施: placebo (Drug)

结局指标

主要结局

The time for first rescue analgesia after the TAP block

时间窗: 24 hours post operative

calculation the time needed for first rescue analgesia after the TAP block

次要结局

  • Total dose of rescue analgesia(24 hours postoperative)
  • Adverse effects(24 hours postoperative)

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

hany farouk

Principal Investigator

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验